NICKI VOGEL: Open Payments
NPI 1437235173 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,896 in 102 payments from 20 companies in 2025. Trend: 2023 $1,987 · 2024 $2,314 · 2025 $1,896
Food & beverage: $1,896
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $392 |
| PFIZER INC. | 16 | $274 |
| ABBVIE INC. | 14 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $151 |
| GlaxoSmithKline, LLC. | 6 | $133 |
| Dexcom, Inc. | 5 | $122 |
| Phathom Pharmaceuticals, Inc. | 6 | $80 |
| Novo Nordisk Inc | 4 | $69 |
| Axsome Therapeutics, Inc. | 2 | $67 |
| Amgen Inc. | 4 | $64 |
Products named: NURTEC ODT, FARXIGA, TRINTELLIX, AIRSUPRA, TRELEGY ELLIPTA, Dexcom G6 Transmitter, QULIPTA, VRAYLAR.
Industry payments across NC — which companies pay providers there.
